Inherited calcium channelopathies in the pathophysiology of arrhythmias (Q38021673)

27 August 2017

title

Inherited calcium channelopathies in the pathophysiology of arrhythmias (English)

1 reference

27 August 2017

1 reference

Luigi Venetucci

1 reference

27 August 2017

Marco Denegri

series ordinal

1 reference

27 August 2017

Carlo Napolitano

series ordinal

1 reference

27 August 2017

Silvia G Priori

series ordinal

1 reference

27 August 2017

language of work or name

English

0 references

publication date

26 June 2012

1 reference

Nature Reviews Cardiology

27 August 2017

published in

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

page(s)

561-575

1 reference

Cardiac excitation-contraction coupling

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Calcium cycling in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Sarcoplasmic reticulum Ca2+ leak in heart failure: mere observation or functional relevance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Cellular basis of triggered arrhythmias in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Luminal Ca2+ controls termination and refractory behavior of Ca2+-induced Ca2+ release in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The assembly of calcium release units in cardiac muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The control of calcium release in heart muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Modulation of excitation-contraction coupling by isoproterenol in cardiomyocytes with controlled SR Ca2+ load and Ca2+ current trigger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Beta-adrenergic receptor signaling in the heart: role of CaMKII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Ryanodine receptor S2808 phosphorylation in heart failure: smoking gun or red herring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Abnormal termination of Ca2+ release is a common defect of RyR2 mutations associated with cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The sarcoplasmic reticulum and arrhythmogenic calcium release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The role of luminal Ca2+ in the generation of Ca2+ waves in rat ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The effect of tetracaine on spontaneous Ca2+ release and sarcoplasmic reticulum calcium content in rat ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Single channel and 45Ca2+ flux measurements of the cardiac sarcoplasmic reticulum calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Regulation of the gating of the sheep cardiac sarcoplasmic reticulum Ca(2+)-release channel by luminal Ca2+.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Putting out the fire: what terminates calcium-induced calcium release in cardiac muscle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

In the RyR2(R4496C) mouse model of CPVT, β-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Mutation-linked defective interdomain interactions within ryanodine receptor cause aberrant Ca²⁺release leading to catecholaminergic polymorphic ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Regulation of cardiac muscle Ca2+ release channel by sarcoplasmic reticulum lumenal Ca2+

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Luminal Ca2+ regulation of single cardiac ryanodine receptors: insights provided by calsequestrin and its mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The calsequestrin mutation CASQ2D307H does not affect protein stability and targeting to the junctional sarcoplasmic reticulum but compromises its dynamic regulation of calcium buffering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The catecholaminergic polymorphic ventricular tachycardia mutation R33Q disrupts the N-terminal structural motif that regulates reversible calsequestrin polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The control of Ca release from the cardiac sarcoplasmic reticulum: regulation versus autoregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Spontaneous Ca waves in ventricular myocytes from failing hearts depend on Ca(2+)-calmodulin-dependent protein kinase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

21 January 2018

Metabolism of flecainide

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Common molecular determinants of flecainide and lidocaine block of heart Na+ channels: evidence from experiments with neutral and quaternary flecainide analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Functional Roles of Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Autoinhibitory control of the CaV1.2 channel by its proteolytically processed distal C-terminal domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Deletion of the Distal C Terminus of CaV1.2 Channels Leads to Loss of β-Adrenergic Regulation and Heart Failure in Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Voltage-gated calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The alpha2delta subunits of voltage-gated calcium channels form GPI-anchored proteins, a posttranslational modification essential for function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Targeted disruption of the voltage-dependent calcium channel alpha2/delta-1-subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Novel functional properties of Ca(2+) channel beta subunits revealed by their expression in adult rat heart cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The β Subunit of Voltage-Gated Ca2+Channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Sodium channel mutations and arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

A single Na(+) channel mutation causing both long-QT and Brugada syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Natural history of Brugada syndrome: insights for risk stratification and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Efficacy of quinidine in high-risk patients with Brugada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Short QT interval in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The QT interval: too long, too short or just right

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The short QT syndrome: proposed diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Sudden death associated with short-QT syndrome linked to mutations in HERG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Mutation in the KCNQ1 gene leading to the short QT-interval syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Short QT syndrome: from bench to bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Short QT syndrome: pharmacological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Long-term follow-up of patients with short QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Comparison of the effect of class IA antiarrhythmic drugs on transmembrane potassium currents in rabbit ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The early repolarization variant--normal or a marker of heart disease in certain subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Sudden cardiac arrest associated with early repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Risk of sudden death among young individuals with J waves and early repolarization: Putting the evidence into perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

J-wave syndromes. from cell to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Mouse model of Timothy syndrome recapitulates triad of autistic traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Effects of [Ca2+]i, SR Ca2+ load, and rest on Ca2+ spark frequency in ventricular myocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Sarcoplasmic reticulum Ca2+ content, L‐type Ca2+ current and the Ca2+ transient in rat myocytes during β‐adrenergic Stimulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Calcium sparks and [Ca2+]i waves in cardiac myocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Increasing Ryanodine Receptor Open Probability Alone Does Not Produce Arrhythmogenic Calcium Waves

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

The effects of low concentrations of caffeine on spontaneous Ca release in isolated rat ventricular myocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibres

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Intravenous epinephrine infusion test in diagnosis of catecholaminergic polymorphic ventricular tachycardia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Effects of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

K201 modulates excitation-contraction coupling and spontaneous Ca2+ release in normal adult rabbit ventricular cardiomyocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Comparison of sarcolemmal calcium channel current in rabbit and rat ventricular myocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Distinguishing "benign" from "malignant early repolarization": the value of the ST-segment morphology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Prevalence of early repolarization pattern in inferolateral leads in patients with Brugada syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

High prevalence of early repolarization in short QT syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Long QT, syndactyly, joint contractures, stroke and novel CACNA1C mutation: expanding the spectrum of Timothy syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Somatic mosaicism contributes to phenotypic variation in Timothy syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Beta-adrenergic modulation of arrhythmogenesis and identification of targeted sites of antiarrhythmic therapy in Timothy (LQT8) syndrome: a theoretical study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.93

Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22733215

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ca2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22733215

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Therapy for the Brugada syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22733215

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCARDIO.2012.93

1 reference

Dimensions Publication ID

27 August 2017

1015609034

0 references

1 reference